UnitedHealthcare news and information

More hospitals and docs are signing accountable care contracts that tie payouts to delivering better results at lower costs. Some want insurers to nudge patients toward choices that help them do it.
FULL STORY »

Both providers and payers have been saying for years that personalized medicine will radically alter the way that cancer patients receive care.
FULL STORY »

Mobile technologies are changing the way healthcare is consumed and delivered in America, paving the way for greater consumer engagement, reduced costs and better patient outcomes. Driving the trend is the growing prevalence of smartphones and tablets, which have empowered consumers like never...
FULL STORY »

PITTSBURGH—Insurer Highmark closed on a deal for its first hospital under a costly plan to diversify and compete with the region's well-financed and largest health system. Jefferson Regional Medical Center, in Jefferson Hills, Pa., will receive $100 million for capital projects under...
FULL STORY »

Lifespan Corp. and insurer UnitedHealthcare will launch an “accountable coordinated-care organization” in Rhode Island on July 1.
FULL STORY »

Hospital stays for mental illness or substance abuse rose as hospital visits for other medical care fell the first year insurers were required to treat behavioral health like any other condition.
FULL STORY »

Gagged by their supply contracts, some hospitals have devised a simple way to educate physicians about the cost of pricey implants: using color-coded stickers to indicate the level of a device's price.
FULL STORY »

The New Mexico Human Service Department has announced that four companies will share around $4 billion in federal money to provide Medicaid to around 700,000 residents next year.
FULL STORY »

The Cleveland Clinic is the latest hospital system to form a joint venture that aims to address the rising costs of hip and knee implants, stents and other pricey physician preference items.
FULL STORY »

Last year, the Utah-based SelectHealth insurance company paid $1 million to provide just five patients with the critical enzyme-replacement drug Cerezyme.
FULL STORY »